Skip to main content
SpringerLink
Log in

MHRA warns of medication errors with transdermal rivastigmine

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Rivastigmine (Exelon) transdermal patch: risk of medication errors. Drug Safety Update 3: 2-3, No. 11, Jun 2010

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

MHRA warns of medication errors with transdermal rivastigmine. React. Wkly. 1305, 2 (2010). https://doi.org/10.2165/00128415-201013050-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013050-00003

Keywords

Search

Navigation